12/26
12:00 pm
qntm
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Low
Report
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
12/25
12:00 pm
qntm
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Low
Report
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
12/23
09:02 am
qntm
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS) [Yahoo! Finance]
High
Report
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS) [Yahoo! Finance]
12/23
08:00 am
qntm
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
High
Report
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
12/22
07:00 am
qntm
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
High
Report
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
12/19
04:52 pm
qntm
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
High
Report
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
12/3
04:33 pm
qntm
Quantum Biopharma (NASDAQ:QNTM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Quantum Biopharma (NASDAQ:QNTM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/1
07:13 am
qntm
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC [Yahoo! Finance]
High
Report
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC [Yahoo! Finance]
12/1
07:00 am
qntm
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
High
Report
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
11/29
12:31 am
qntm
Quantum Biopharma (NASDAQ:QNTM) was upgraded by analysts at
Wall Street
High
Report
Quantum Biopharma (NASDAQ:QNTM) was upgraded by analysts at
Wall Street
11/28
10:01 am
qntm
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC [Yahoo! Finance]
Medium
Report
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC [Yahoo! Finance]
11/28
09:30 am
qntm
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
High
Report
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
11/27
04:57 pm
qntm
Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC [Yahoo! Finance]
High
Report
Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC [Yahoo! Finance]
11/27
04:00 pm
qntm
Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
High
Report
Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
11/27
02:52 pm
qntm
Quantum Biopharma (NASDAQ:QNTM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
Quantum Biopharma (NASDAQ:QNTM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/27
05:12 am
qntm
‘Market manipulation' cases trending up in Canada: regulator data [BNN Bloomberg (Canada)]
High
Report
‘Market manipulation' cases trending up in Canada: regulator data [BNN Bloomberg (Canada)]
11/26
09:30 am
qntm
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
High
Report
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
11/26
05:02 am
qntm
Inside a Canadian biotech firm's fight to prove it's a victim of ‘stock spoofing' [BNN Bloomberg (Canada)]
High
Report
Inside a Canadian biotech firm's fight to prove it's a victim of ‘stock spoofing' [BNN Bloomberg (Canada)]
11/25
04:56 pm
qntm
Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 [Yahoo! Finance]
High
Report
Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 [Yahoo! Finance]
11/25
04:00 pm
qntm
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
High
Report
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
11/25
05:03 am
qntm
Was a Canadian company's multiple sclerosis research nearly derailed by “market manipulation”? [BNN Bloomberg (Canada)]
High
Report
Was a Canadian company's multiple sclerosis research nearly derailed by “market manipulation”? [BNN Bloomberg (Canada)]
11/21
02:05 pm
qntm
Quantum Biopharma (NASDAQ:QNTM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Quantum Biopharma (NASDAQ:QNTM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/7
07:00 am
qntm
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio
Medium
Report
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio
10/31
09:28 pm
qntm
Quantum BioPharma Ltd. Provides Corporate Update [Canadian Business Journal (Canada)]
Low
Report
Quantum BioPharma Ltd. Provides Corporate Update [Canadian Business Journal (Canada)]
10/31
08:08 pm
qntm
Quantum BioPharma Ltd. Provides Corporate Update [Yahoo! Finance]
Low
Report
Quantum BioPharma Ltd. Provides Corporate Update [Yahoo! Finance]